Tag: Sanofi

Indian Company Collaborates with Sanofi in CNS Area

Jubilant Biosys, a Bengaluru-based subsidiary of Jubilant Life Sciences, announced a new integrated drug discovery collaboration with Sanofi in the CNS therapeutic area. The first collaboration with S...

Sanofi and Regeneron Slash Price for Praluent by 60%

Sanofi SA and Regeneron Pharmaceuticals Inc said on Monday that they will slash the U.S. list price of their potent but expensive cholesterol fighter Praluent by 60 percent, as the drugmakers follow a...

Egypt and Sanofi Discussed Expanding Cooperation in Africa

Egyption Public Business Sector Minister Hisham Tawfiq said that chairman of the Holding Company for Pharmaceuticals, Chemicals and Medical Supplies Ahmed Hegazi will visit Chad next week to discuss t...

Big Pharma to Testify in High Drug Pricing Case

While congressional scrutiny on drug pricing is nothing new, the prospect of some of the pharmaceutical industry's highest-profile CEOs testifying on the issue will make for a must-watch event. In ...

Rare Disease Drug Approved, Receiving ODD

The U.S. Food and Drug Administration today approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in combination with plasma exchange and immunosuppressive therapy,...

Drug Giants Should Explain High Prices on Insulin

Sanofi, Eli Lilly and Novo Nordisk have been sent letters by US lawmakers requesting information on the increased costs of insulin in recent years and the companies’ profit from sales of these product...

GSK and Sanofi Take Part in FinnGen

GlaxoSmithKline and Sanofi have joined academic groups and other pharma companies to take part in Finland’s large scale genomics project, based on data from 500,000 biobank volunteers. FinnGen aims...

FDA Votes Divided on Sanofi’s Diabetes Drug

The future of Sanofi and Lexicon’s oral diabetes drug Zynquista hangs in the balance after an FDA advisory committee was split on whether the drug would benefit patients. The Endocrinologic and Met...

Sanofi to Develop Antibodies with BiXAb Platform

sanofi
Biomunex Pharmaceuticals has signed a licensing agreement with Sanofi for the development of bi-specific and multi-specific antibody therapeutics. As part of the deal, Sanofi will use the BiXAb pla...

BioNTech and Sanofi to Co-develop Cancer Immunotherapy

French multinational pharmaceutical company Sanofi investing €80m in equity in BioNTech, which is claimed to be the Europe’s largest privately-held biopharmaceutical firm focused on the development of...

Sanofi Gives Back Rights for Drugs to MyoKardia

Sanofi has walked away from a four-year-old alliance with US biotech MyoKardia, handing back rights to three drugs for heart disease. The decision comes ahead of data readouts for two of the clinic...

Sanofi’s Pediatric Vaccine Approved by FDA

The US Food and Drug Administration (FDA) has approved Sanofi’s pediatric hexavalent combination vaccine for use in children between six weeks and five years of age. The vaccine, called Vaxelis, is...

Opiant and Sanofi to Develop Drinabant for ACO

Opiant Pharmaceuticals has signed a licensing agreement with Sanofi for the development and commercialisation of drinabant across the globe for the treatment of acute cannabinoid overdose (ACO). AC...

Hong Kong stops vaccination service because of Sanofi-Aventis’ vaccines

malaria vaccine
Hong Kong's Department of Health as informed by Sanofi-Aventis, that it has decided to take a precautionary measure to suspend the supply of a batch of quadrivalent seasonal influenza vaccines.

Sanofi to establish a research institute in China

sanofi-china
French pharmaceutical company Sanofi is planning to set up its first research institute in the eastern city of Suzhou (China) to further expand its presence in the world's most populous country.

Sanofi conducted the China Health Road Symposium in Shanghai

sanofi-china
Sanofi held the China Health Road Symposium in Shanghai (China) during the first edition of China International Import Expo (CIIE) exhibition that was conducted for five days